Prometheus Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Prometheus Biosciences's estimated annual revenue is currently $2.6M per year.
- Prometheus Biosciences's estimated revenue per employee is $25,600
- Prometheus Biosciences's total funding is $451.8M.
- Prometheus Biosciences's current valuation is $1.4B. (January 2022)
Employee Data
- Prometheus Biosciences has 100 Employees.
- Prometheus Biosciences grew their employee count by 0% last year.
Prometheus Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP - Precision Bioinformatics | Reveal Email/Phone |
2 | VP, Clinical Operations | Reveal Email/Phone |
3 | VP | Pipeline Strategy | Reveal Email/Phone |
4 | General Counsel | Reveal Email/Phone |
5 | VP, Clinical Development | Reveal Email/Phone |
6 | VP, Biostatistics & Data Management | Reveal Email/Phone |
7 | VP Investor Relations and Communications | Reveal Email/Phone |
8 | SVP Finance | Reveal Email/Phone |
9 | Associate Director | Reveal Email/Phone |
10 | Associate Director, R&D | Reveal Email/Phone |
Prometheus Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Prometheus Biosciences?
Prometheus Biosciences, Inc., is a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases.
keywords:N/A
$451.8M
Total Funding
100
Number of Employees
$2.6M
Revenue (est)
0%
Employee Growth %
$1.4B
Valuation
N/A
Accelerator
Prometheus Biosciences News
In trading on Monday, shares of Prometheus Biosciences Inc (Symbol: RXDX) crossed below their 200 day moving average of $31.68,...
... Cornerstones Health, and Imedex; and as a consultant or adviser to Boehringer Ingelheim, Gilead Sciences, Prometheus Biosciences, Takeda, UCB Biopharma,...
Prometheus Biosciences Initiates Third Phase 2 Study of PRA023 for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD).
SAN DIEGO, Dec. 15, 2020 /PRNewswire/ -- Prometheus Biosciences, Inc. ("Prometheus"), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the diagnosis and treatment of ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.5M | 100 | 11% | N/A |
#2 | $22M | 100 | 9% | N/A |
#3 | $14.5M | 100 | 5% | N/A |
#4 | $16.5M | 100 | 0% | N/A |
#5 | $27M | 100 | -1% | N/A |